DMAC
DiaMedica Therapeutics Inc
NASDAQ: DMAC · HEALTHCARE · BIOTECHNOLOGY
$6.05
+1.51% today
Updated 2026-04-30
Market cap
$341.08M
P/E ratio
—
P/S ratio
66.68x
EPS (TTM)
$-0.70
Dividend yield
—
52W range
$3 – $10
Volume
0.2M
DiaMedica Therapeutics Inc (DMAC) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |